ArticleRespiration; international review of thoracic diseases2026
Real-World Experience of Prolonged Treatment for Treatment-Refractory Nontuberculous Mycobacterial Pulmonary Disease: Benefits and Harms of Extending Therapy beyond 24 Months.
Hyung-Jun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.